(Q48432586)

English

A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.

scientific article published in September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672081%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672081%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Victoria A Reed

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672081%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

K Bowering

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672081%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

J S Felicio

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672081%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

J Landry

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672081%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

L Ji

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672081%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

J Oliveira

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672081%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

1 September 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672081%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Diabetic Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672081%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672081%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672081%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

e263-72

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672081%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03722.X

21 January 2018

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03722.X

21 January 2018

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03722.X

21 January 2018

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03722.X

21 January 2018

Premixed insulin treatment for type 2 diabetes: analogue or human?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03722.X

21 January 2018

Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03722.X

21 January 2018

Prandial-basal insulin regimens plus oral antihyperglycaemic agents to improve mealtime glycaemia: initiate and progressively advance insulin therapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03722.X

21 January 2018

Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03722.X

21 January 2018

Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03722.X

21 January 2018

Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03722.X

21 January 2018

Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03722.X

21 January 2018

Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03722.X

21 January 2018

Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03722.X

21 January 2018

Three-year efficacy of complex insulin regimens in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2012.03722.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2012.03722.X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672081%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22672081%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48432586&oldid=1244971637"